nodes	percent_of_prediction	percent_of_DWPC	metapath
Chloroquine—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.774	1	CbGbCtD
Chloroquine—Personality change—Riluzole—amyotrophic lateral sclerosis	0.0246	0.231	CcSEcCtD
Chloroquine—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.00626	0.0587	CcSEcCtD
Chloroquine—Quinacrine—PLA2G4A—amyotrophic lateral sclerosis	0.00574	1	CrCbGaD
Chloroquine—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00548	0.0514	CcSEcCtD
Chloroquine—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00442	0.0415	CcSEcCtD
Chloroquine—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00389	0.0365	CcSEcCtD
Chloroquine—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00362	0.034	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00353	0.0331	CcSEcCtD
Chloroquine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00334	0.0313	CcSEcCtD
Chloroquine—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00281	0.0263	CcSEcCtD
Chloroquine—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00276	0.0259	CcSEcCtD
Chloroquine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.0027	0.0253	CcSEcCtD
Chloroquine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00246	0.0231	CcSEcCtD
Chloroquine—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00237	0.0222	CcSEcCtD
Chloroquine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00235	0.0221	CcSEcCtD
Chloroquine—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00224	0.021	CcSEcCtD
Chloroquine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00209	0.0196	CcSEcCtD
Chloroquine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00189	0.0178	CcSEcCtD
Chloroquine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00188	0.0177	CcSEcCtD
Chloroquine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00178	0.0167	CcSEcCtD
Chloroquine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00175	0.0164	CcSEcCtD
Chloroquine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00169	0.0159	CcSEcCtD
Chloroquine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00168	0.0158	CcSEcCtD
Chloroquine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00165	0.0154	CcSEcCtD
Chloroquine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.0016	0.015	CcSEcCtD
Chloroquine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00157	0.0147	CcSEcCtD
Chloroquine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00152	0.0143	CcSEcCtD
Chloroquine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00146	0.0137	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00145	0.0136	CcSEcCtD
Chloroquine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00138	0.013	CcSEcCtD
Chloroquine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00134	0.0125	CcSEcCtD
Chloroquine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00133	0.0125	CcSEcCtD
Chloroquine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00121	0.0113	CcSEcCtD
Chloroquine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00119	0.0112	CcSEcCtD
Chloroquine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00115	0.0108	CcSEcCtD
Chloroquine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00107	0.01	CcSEcCtD
Chloroquine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00994	CcSEcCtD
Chloroquine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00988	CcSEcCtD
Chloroquine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000998	0.00937	CcSEcCtD
Chloroquine—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—APOE—amyotrophic lateral sclerosis	0.000452	0.00398	CbGpPWpGaD
Chloroquine—TNF—TNF alpha Signaling Pathway—CASP9—amyotrophic lateral sclerosis	0.00044	0.00387	CbGpPWpGaD
Chloroquine—TNF—Matrix Metalloproteinases—MMP9—amyotrophic lateral sclerosis	0.000429	0.00377	CbGpPWpGaD
Chloroquine—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CASP3—amyotrophic lateral sclerosis	0.00042	0.0037	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000411	0.00362	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000411	0.00362	CbGpPWpGaD
Chloroquine—TNF—Apoptosis—MAPT—amyotrophic lateral sclerosis	0.00041	0.00361	CbGpPWpGaD
Chloroquine—TNF—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000409	0.0036	CbGpPWpGaD
Chloroquine—TNF—amb2 Integrin signaling—MMP9—amyotrophic lateral sclerosis	0.000407	0.00358	CbGpPWpGaD
Chloroquine—TNF—Ceramide signaling pathway—IGF1—amyotrophic lateral sclerosis	0.000405	0.00356	CbGpPWpGaD
Chloroquine—CYP1A1—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000402	0.00354	CbGpPWpGaD
Chloroquine—TNF—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.0004	0.00352	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—MAPT—amyotrophic lateral sclerosis	0.000385	0.00339	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000376	0.00331	CbGpPWpGaD
Chloroquine—TNF—Amyotrophic lateral sclerosis (ALS)—CASP3—amyotrophic lateral sclerosis	0.000375	0.0033	CbGpPWpGaD
Chloroquine—TNF—Cardiac Hypertrophic Response—IGF1—amyotrophic lateral sclerosis	0.000363	0.00319	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000354	0.00311	CbGpPWpGaD
Chloroquine—TNF—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000353	0.00311	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00035	0.00308	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000347	0.00306	CbGpPWpGaD
Chloroquine—TNF—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.000347	0.00306	CbGpPWpGaD
Chloroquine—TNF—FAS pathway and Stress induction of HSP regulation—CASP3—amyotrophic lateral sclerosis	0.000347	0.00305	CbGpPWpGaD
Chloroquine—TNF—TWEAK Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.000347	0.00305	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000337	0.00297	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000329	0.0029	CbGpPWpGaD
Chloroquine—TNF—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.000329	0.00289	CbGpPWpGaD
Chloroquine—TNF—TWEAK Signaling Pathway—MMP9—amyotrophic lateral sclerosis	0.000328	0.00288	CbGpPWpGaD
Chloroquine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—amyotrophic lateral sclerosis	0.000325	0.00286	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000317	0.00279	CbGpPWpGaD
Chloroquine—CYP1A1—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000316	0.00278	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.000304	0.00267	CbGpPWpGaD
Chloroquine—CYP3A5—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000303	0.00267	CbGpPWpGaD
Chloroquine—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000303	0.00266	CbGpPWpGaD
Chloroquine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.000301	0.00265	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000297	0.00262	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—ATF1—amyotrophic lateral sclerosis	0.000292	0.00257	CbGpPWpGaD
Chloroquine—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00029	0.00255	CbGpPWpGaD
Chloroquine—TNF—Apoptosis—CASP9—amyotrophic lateral sclerosis	0.00029	0.00255	CbGpPWpGaD
Chloroquine—CYP1A1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000286	0.00252	CbGpPWpGaD
Chloroquine—TLR9—Immune System—DCTN1—amyotrophic lateral sclerosis	0.000284	0.0025	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—CASP9—amyotrophic lateral sclerosis	0.000278	0.00245	CbGpPWpGaD
Chloroquine—TNF—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000273	0.00241	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000272	0.00239	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—CASP9—amyotrophic lateral sclerosis	0.000271	0.00239	CbGpPWpGaD
Chloroquine—TNF—Caspase Cascade in Apoptosis—CASP3—amyotrophic lateral sclerosis	0.000271	0.00239	CbGpPWpGaD
Chloroquine—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000262	0.00231	CbGpPWpGaD
Chloroquine—TNF—MicroRNAs in cardiomyocyte hypertrophy—IGF1—amyotrophic lateral sclerosis	0.000259	0.00228	CbGpPWpGaD
Chloroquine—TNF—Apoptosis—IGF1—amyotrophic lateral sclerosis	0.000259	0.00228	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000245	0.00216	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000243	0.00214	CbGpPWpGaD
Chloroquine—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—amyotrophic lateral sclerosis	0.000241	0.00212	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	0.000238	0.00209	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—BDNF—amyotrophic lateral sclerosis	0.000229	0.00201	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000225	0.00198	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000225	0.00198	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000221	0.00195	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00022	0.00194	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000218	0.00192	CbGpPWpGaD
Chloroquine—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000215	0.0019	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000213	0.00187	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000212	0.00186	CbGpPWpGaD
Chloroquine—TNF—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.000209	0.00184	CbGpPWpGaD
Chloroquine—TNF—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	0.000209	0.00184	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000208	0.00183	CbGpPWpGaD
Chloroquine—TNF—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000207	0.00182	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000207	0.00182	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000202	0.00178	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000202	0.00177	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000201	0.00176	CbGpPWpGaD
Chloroquine—TNF—Apoptosis—CASP3—amyotrophic lateral sclerosis	0.000199	0.00175	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—C3—amyotrophic lateral sclerosis	0.000198	0.00174	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000197	0.00174	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000194	0.00171	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.000191	0.00168	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000187	0.00165	CbGpPWpGaD
Chloroquine—TNF—TNF alpha Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.000185	0.00163	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000185	0.00163	CbGpPWpGaD
Chloroquine—TNF—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.000182	0.00161	CbGpPWpGaD
Chloroquine—TLR9—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000181	0.00159	CbGpPWpGaD
Chloroquine—CYP1A1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000178	0.00157	CbGpPWpGaD
Chloroquine—TNF—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	0.000177	0.00156	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000176	0.00155	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.000175	0.00154	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000172	0.00152	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000172	0.00151	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000171	0.0015	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00017	0.0015	CbGpPWpGaD
Chloroquine—TLR9—Immune System—ATF1—amyotrophic lateral sclerosis	0.00017	0.0015	CbGpPWpGaD
Chloroquine—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000163	0.00144	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—PTGS2—amyotrophic lateral sclerosis	0.000163	0.00144	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CASP9—amyotrophic lateral sclerosis	0.000162	0.00142	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000162	0.00142	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000155	0.00136	CbGpPWpGaD
Chloroquine—TNF—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.000155	0.00136	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000152	0.00134	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.000152	0.00133	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.00015	0.00132	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000148	0.0013	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	0.000143	0.00126	CbGpPWpGaD
Chloroquine—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000141	0.00124	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000139	0.00122	CbGpPWpGaD
Chloroquine—TLR9—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000139	0.00122	CbGpPWpGaD
Chloroquine—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000136	0.00119	CbGpPWpGaD
Chloroquine—TNF—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.000134	0.00118	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000134	0.00118	CbGpPWpGaD
Chloroquine—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000134	0.00118	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CD40LG—amyotrophic lateral sclerosis	0.00013	0.00115	CbGpPWpGaD
Chloroquine—CYP1A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000128	0.00113	CbGpPWpGaD
Chloroquine—TNF—Apoptosis—TP53—amyotrophic lateral sclerosis	0.000128	0.00112	CbGpPWpGaD
Chloroquine—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000127	0.00112	CbGpPWpGaD
Chloroquine—CYP1A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000126	0.00111	CbGpPWpGaD
Chloroquine—TNF—Apoptosis—CASP3—amyotrophic lateral sclerosis	0.000122	0.00107	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000121	0.00107	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000121	0.00106	CbGpPWpGaD
Chloroquine—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000117	0.00103	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000117	0.00103	CbGpPWpGaD
Chloroquine—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000116	0.00102	CbGpPWpGaD
Chloroquine—TLR9—Immune System—C3—amyotrophic lateral sclerosis	0.000115	0.00101	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.000114	0.00101	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000111	0.000978	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000111	0.000974	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00011	0.000967	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000107	0.000945	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000105	0.000921	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000104	0.000914	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000104	0.000914	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000103	0.000908	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000103	0.000906	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—VAPB—amyotrophic lateral sclerosis	9.81e-05	0.000864	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—TPK1—amyotrophic lateral sclerosis	9.81e-05	0.000864	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	9.73e-05	0.000856	CbGpPWpGaD
Chloroquine—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.64e-05	0.000848	CbGpPWpGaD
Chloroquine—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.51e-05	0.000837	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	9.5e-05	0.000836	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.18e-05	0.000808	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	9.17e-05	0.000807	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.15e-05	0.000805	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	9.05e-05	0.000797	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	9e-05	0.000792	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	9e-05	0.000792	CbGpPWpGaD
Chloroquine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	8.98e-05	0.000791	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	8.98e-05	0.00079	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.96e-05	0.000788	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.83e-05	0.000777	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	8.76e-05	0.000771	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	8.64e-05	0.000761	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.44e-05	0.000743	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.42e-05	0.000741	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	8.39e-05	0.000738	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.34e-05	0.000734	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	8.3e-05	0.000731	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	8.23e-05	0.000724	CbGpPWpGaD
Chloroquine—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	8.17e-05	0.000719	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	7.85e-05	0.000691	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	7.84e-05	0.00069	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	7.84e-05	0.00069	CbGpPWpGaD
Chloroquine—TNF—Apoptosis—TP53—amyotrophic lateral sclerosis	7.82e-05	0.000688	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	7.78e-05	0.000685	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.65e-05	0.000673	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	7.51e-05	0.000661	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.44e-05	0.000655	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	7.39e-05	0.00065	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	7.39e-05	0.00065	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—TP53—amyotrophic lateral sclerosis	7.33e-05	0.000645	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	7.19e-05	0.000633	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	7.17e-05	0.000631	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	7.09e-05	0.000624	CbGpPWpGaD
Chloroquine—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.95e-05	0.000612	CbGpPWpGaD
Chloroquine—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.95e-05	0.000612	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—APOE—amyotrophic lateral sclerosis	6.94e-05	0.000611	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.93e-05	0.00061	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	6.76e-05	0.000595	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.66e-05	0.000587	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	6.62e-05	0.000582	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	6.5e-05	0.000573	CbGpPWpGaD
Chloroquine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.3e-05	0.000555	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.28e-05	0.000553	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	6.27e-05	0.000552	CbGpPWpGaD
Chloroquine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.22e-05	0.000547	CbGpPWpGaD
Chloroquine—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.19e-05	0.000545	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	5.9e-05	0.00052	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	5.88e-05	0.000517	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.72e-05	0.000504	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	5.69e-05	0.000501	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	5.67e-05	0.000499	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	5.38e-05	0.000473	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	5.34e-05	0.00047	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	5.25e-05	0.000462	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	4.96e-05	0.000437	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	4.93e-05	0.000434	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	4.87e-05	0.000429	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	4.83e-05	0.000425	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	4.83e-05	0.000425	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.76e-05	0.000419	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—MMP9—amyotrophic lateral sclerosis	4.56e-05	0.000401	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	4.55e-05	0.0004	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	4.52e-05	0.000398	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.52e-05	0.000398	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	4.42e-05	0.000389	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.41e-05	0.000388	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	4.31e-05	0.00038	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	4.29e-05	0.000378	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.16e-05	0.000367	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.14e-05	0.000365	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.11e-05	0.000361	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	4.09e-05	0.00036	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	4.07e-05	0.000359	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	4.05e-05	0.000356	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	3.96e-05	0.000349	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	3.86e-05	0.00034	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	3.84e-05	0.000338	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.74e-05	0.000329	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	3.74e-05	0.000329	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	3.73e-05	0.000329	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.72e-05	0.000327	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	3.49e-05	0.000307	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.41e-05	0.0003	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.25e-05	0.000286	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	3.07e-05	0.00027	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.9e-05	0.000255	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.83e-05	0.000249	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	2.65e-05	0.000233	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.55e-05	0.000224	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	2.44e-05	0.000215	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.34e-05	0.000206	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.32e-05	0.000204	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.19e-05	0.000193	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.13e-05	0.000187	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.01e-05	0.000177	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.01e-05	0.000177	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.01e-05	0.000176	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.85e-05	0.000162	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	1.75e-05	0.000154	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.75e-05	0.000154	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	1.66e-05	0.000146	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.65e-05	0.000145	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.61e-05	0.000141	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	1.52e-05	0.000134	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.51e-05	0.000133	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	1.32e-05	0.000116	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	1.25e-05	0.00011	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.2e-05	0.000106	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.13e-05	9.99e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.08e-05	9.49e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.04e-05	9.16e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.9e-06	8.72e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.06e-06	7.98e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.54e-06	7.52e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	8.15e-06	7.17e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.58e-06	4.91e-05	CbGpPWpGaD
